查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985758

疝气修补市场：依产品类型、手术方法、疝气类型和最终用户划分－2026-2032年全球市场预测

Hernia Repair Market by Product Type, Procedure Type, Hernia Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，疝气修补市场价值将达到 50.4 亿美元，到 2026 年将成长至 53.1 亿美元，到 2032 年将达到 73.1 亿美元，复合年增长率为 5.45%。

主要市场统计数据
基准年 2025 50.4亿美元
预计年份：2026年 53.1亿美元
预测年份 2032 73.1亿美元
复合年增长率 (%) 5.45%

这篇前瞻性的介绍总结了外部技术的进步、材料的创新以及医疗保健服务模式的变化如何重塑临床实践和供应商的策略。

疝气修补手术在外科创新、材料科学和不断变化的医疗服务模式的交汇点上不断发展。本执行摘要整合了影响该领域的当代驱动因素，重点介绍了供应商和医疗服务提供者面临的关键转折点，并阐述了对整个医疗流程中的相关人员有重大影响的机会。

对疝气修补术中技术、程序和监管变革的融合进行分析性回顾，这些变革正在重新定义产品要求和临床引入途径。

疝气修补领域正经历一场变革，其驱动力来自技术进步、政策转变以及不断变化的临床需求。生物材料和合成支架的进步催生了新一代植入，这些植入物强调生物相容性、个人化降解特性以及表面工程，从而降低感染和沾黏的风险。这些材料创新并非孤立存在，而是与手术趋势相互作用，尤其是微创技术的广泛应用，重塑了产品需求和性能标准。

对 2025 年预期关税变化将如何影响疝气修復相关人员的采购、供应链韧性和策略采购进行全面评估。

美国预计2025年进行的关税调整将为疝气修补器材的筹资策略和全球供应链规划带来新的复杂性。关税趋势可能会影响进口原料和成品植入的成本结构，进而影响采购决策、库存策略和商业定价。与跨境供应商建立合作关係的企业需要重新审视合约条款、物流路线和关税减免策略，以保持竞争力。

基于详细的细分观点，将材料分类、手术亚型、解剖适应症和临床环境联繫起来，制定个人化的临床和商业策略。

基于细分市场的洞察对于理解个人产品特性、手术方法、疝气类型和医疗环境如何相互交织，进而影响临床决策和商业策略至关重要。在考虑产品类型时，分析必须区分生物网膜和合成网片。生物网膜片又可再细分为动物源性和人源性结构，而合成网片则包括聚酯、聚丙烯和聚四氟乙烯等不同材质，每种材质都有独特的操作性、组织整合性和抗感染性。这些材料差异会影响外科医师的选择偏好、消毒通讯协定以及对术后管理的预期。

透过精细的区域分析，指导市场进入和业务扩张计划，协调美洲、欧洲、中东和非洲以及亚太地区不同临床实践、管理体制和供应链的实际情况。

区域趋势对临床实践模式、监管预期和供应链结构产生显着影响，从而在不同地区形成独特的策略考量。在美洲，大规模学术医疗中心和不断扩展的门诊手术中心网路对医疗服务至关重要，这些因素共同推动了对兼具卓越临床性能和高效运作的医疗设备的需求。报销模式以及公共和私人保险公司的组成也影响着采购重点和证据要求。

透过策略整合竞争因素、创新重点领域和伙伴关係模式，重新定义疝气修补市场的差异化和价值创造。

疝气修补领域的竞争动态反映了传统外科医疗设备领导企业与生物材料和固定技术领域新兴创新者之间的平衡。大型企业持续投资于聚合物和生物基支架的迭代改进、微创手术的先进输送系统，并致力于提供证据以支持基于价值的采购策略。同时，小规模的专业公司则专注于突破性的材料化学、表面改质以及抗菌涂层和可吸收固定装置等添加剂技术。

为疝气修復领域的领导者提供切实可行的建议，使研发、供应链和商业模式与临床结果和支付方期望保持一致。

产业领导者可以透过将研发、商业和营运重点与临床和支付方的需求相结合，采取果断行动，将新兴趋势转化为永续优势。首先，他们应优先投资于能够显着改善与医疗机构整合、降低感染风险并简化开放式和腹腔镜手术移植流程的材料和输送系统，并以可操作的临床终点和真实世界数据收集工作为支撑。其次，他们应制定跨部门的循证蓝图，纳入外科医生主导的註册登记和上市后监测，以满足监管机构和购买方的需求，同时缩短产品迭代改进的反馈週期。

为了检验结论和建议，我们采用了一种透明的混合方法研究设计，结合了临床医生的见解、监管和临床文献综述以及供应链情境分析。

为支持这份执行报告，研究系统性地整合了多种一手和二手资讯收集方法，旨在确保分析的严谨性和实用性。一手资讯包括对一般外科和微创外科临床专家、门诊、诊所和医院的采购经理以及生物材料和监管事务专家进行的结构化访谈。这些定性讨论有助于提出假设，并帮助确定需要进一步深入分析的优先领域。

一份权威的综合报告，强调了将临床证据、营运韧性和个人化商业化相结合以改善结果和提供永续价值的必要性。

总而言之，疝气修补领域正处于一个转折点，其驱动力来自材料创新、微创技术的进步以及受区域环境和贸易政策变化影响的采购趋势转变。在临床差异化和营运效率同等重要的竞争环境中，将严谨的临床证据产生与切实可行的供应链和商业化策略相结合的相关人员将获得策略优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 疝气修补市场：依产品类型划分

  • 生物网膜
    • 动物源性
    • 人类
  • 复合网格
    • 聚酯纤维
    • 聚丙烯
    • 聚四氟乙烯

第九章 疝气修补术市场（依手术方法划分）

  • 腹腔镜
    • 完全腹膜外法
    • 经腹膜前入路
  • 开放性手术

第十章：疝气修补市场（依疝气类型划分）

  • 食道裂孔疝
  • 切口疝
  • 鼠蹊部
  • 脐疝气
  • 腹壁疝

第十一章 疝气修补市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 疝气修补市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 疝气修补市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 疝气修补市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国疝气修补市场

第十六章：中国疝气修补市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AbbVie Inc.
  • Aran Biomedical by Integer Holdings Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast A/S
  • CooperSurgical, Inc.
  • Cousin Surgery
  • Deep Blue Medical Advances, Inc.
  • Dolphin Sutures
  • Getinge AB
  • HERNIAMESH Srl
  • Hwainmedi Co., Ltd.
  • Insightra Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KATSAN Katgut Sanayi ve Tic. AS
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Momentis Surgical Ltd.
  • Novus Scientific AB
  • Olympus Corporation
  • Secant Group, LLC
  • Surgimatix, Inc.
  • TELA Bio, Inc.
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-351BAD5033FF

The Hernia Repair Market was valued at USD 5.04 billion in 2025 and is projected to grow to USD 5.31 billion in 2026, with a CAGR of 5.45%, reaching USD 7.31 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.04 billion
Estimated Year [2026] USD 5.31 billion
Forecast Year [2032] USD 7.31 billion
CAGR (%) 5.45%

A forward-looking introduction synthesizing surgical evolution, material innovation, and care model shifts that are reshaping clinical practice and supplier strategies

Hernia repair continues to evolve at the intersection of surgical innovation, material science, and shifting care delivery models. This executive summary synthesizes contemporary drivers shaping the field, highlights inflection points for suppliers and providers, and frames high-impact opportunities for stakeholders across the care continuum.

Clinical practice now emphasizes outcomes beyond simple recurrence metrics, with tissue integration, infection resistance, and patient-reported recovery experience gaining prominence. Concurrently, device manufacturers are refining material formulations and scaffold architectures to address both acute and chronic repair needs, while health systems press for procedures that reduce length of stay and readmission risk. As minimally invasive approaches expand, perioperative pathways and device compatibility with laparoscopic techniques are increasingly decisive factors for procurement and adoption.

Regulatory scrutiny and payer engagement continue to influence product development strategies and evidence generation priorities, prompting manufacturers to integrate real-world data and comparative-effectiveness endpoints into their clinical programs. Moreover, cross-disciplinary collaboration among surgeons, materials scientists, and regulatory experts is accelerating translational steps from bench innovations to bedside adoption. The following sections unpack these dynamics and offer pragmatic insights for leaders navigating this complex landscape.

An analytical review of converging technological, procedural, and regulatory shifts that are redefining product requirements and clinical adoption pathways in hernia repair

The hernia repair landscape is undergoing transformative shifts driven by converging technological advances, policy changes, and evolving clinical expectations. Advances in biomaterials and synthetic scaffolds are enabling next-generation implants that emphasize biocompatibility, tailored degradation profiles, and surface engineering to mitigate infection and adhesion risks. These material innovations are not isolated; they interact with procedural trends-particularly the broader adoption of minimally invasive techniques-to reshape product requirements and performance benchmarks.

Parallel to technological progress, healthcare delivery models are moving care episodes from inpatient wards to ambulatory settings wherever clinically appropriate, prompting product design considerations for ease of use, sterility assurance, and the facilitation of shorter recovery pathways. Regulatory pathways are also adapting, with authorities increasingly requiring robust clinical endpoints and post-market surveillance strategies, which in turn drive manufacturers to invest in longer-term outcome studies and real-world evidence systems.

Collectively, these factors create a higher bar for clinical differentiation while opening opportunities for companies that align device features with workflow efficiencies and evidence generation. Payers and hospitals are simultaneously rationalizing device formularies and care bundles, making collaborative value demonstration and interoperability with standard surgical platforms decisive for market penetration.

A comprehensive assessment of how anticipated 2025 tariff shifts will affect procurement, supply chain resilience, and strategic sourcing for hernia repair stakeholders

Anticipated tariff adjustments in the United States in 2025 introduce a layer of complexity to procurement strategies and global supply chain planning for hernia repair devices. Tariff dynamics can influence cost structures for imported materials and finished implants, and they therefore affect sourcing decisions, inventory strategies, and commercial pricing. Organizations that manage cross-border supplier relationships must reassess contractual terms, logistics routing, and duty mitigation strategies to preserve competitiveness.

In response to tariff-driven cost pressures, manufacturers and healthcare systems may re-evaluate localization of production, increase emphasis on regional supplier diversification, and refine total landed cost models rather than relying on unit price alone. Such adjustments can accelerate trends toward nearshoring or strategic stockpiling of critical components, while also prompting more rigorous supplier performance analytics to identify resilience gaps.

Clinically, tariff-related cost shifts could influence hospital procurement committees' device selection criteria and negotiations with vendors, particularly where alternative materials or domestic suppliers offer comparable clinical performance. Importantly, the cumulative impact of tariffs is not limited to price alone; it also affects timelines for technology transfer, regulatory submissions tied to manufacturing changes, and long-term partnerships. Organizations that proactively model tariff scenarios and integrate them into commercial and operational planning will mitigate disruption and preserve strategic flexibility.

A deep segmentation-driven perspective linking material classes, procedural subtypes, anatomical indications, and care settings to inform tailored clinical and commercial strategies

Segmentation insight is essential to understand how distinct product characteristics, procedural approaches, hernia types, and care settings intersect to shape clinical decision-making and commercial strategy. When considering product type, analyses must differentiate between Biological Mesh and Synthetic Mesh; the Biological Mesh category further divides into animal-derived and human-derived constructs, while Synthetic Mesh encompasses polyester, polypropylene, and polytetrafluoroethylene variants, each presenting unique handling, integration, and infection-resistance profiles. These material distinctions influence surgeon preference, sterilization protocols, and postoperative management expectations.

Procedure type segmentation distinguishes laparoscopic from open approaches, with laparoscopic techniques further classified into total extraperitoneal and transabdominal preperitoneal methods. Device design and delivery systems need to align with these procedural subtypes to ensure compatibility with trocar sizes, fixation strategies, and visualization workflows. Meanwhile, hernia type segmentation across hiatal, incisional, inguinal, umbilical, and ventral presentations underscores the need for tailored implant geometries, fixation options, and perioperative care pathways that reflect anatomical and biomechanical variations.

End user segmentation divides the landscape among ambulatory surgical centers, clinics, and hospitals, each with different procurement cycles, case mixes, and facility resources. Ambulatory centers prioritize fast turnover and simplified supply chains, clinics may focus on outpatient continuity of care, and hospitals must balance complex, high-acuity cases with broader procurement governance. Integrating these segmentation lenses enables targeted product positioning, evidence generation plans, and commercialization tactics that resonate with the specific operational realities of each buyer type.

A nuanced regional analysis that aligns divergent clinical practices, regulatory regimes, and supply chain realities across the Americas, EMEA, and Asia-Pacific to guide market entry and scale plans

Regional dynamics exert substantial influence over clinical practice patterns, regulatory expectations, and supply chain architectures, creating distinct strategic considerations across geographies. In the Americas, healthcare delivery emphasizes both large academic centers and an expanding network of ambulatory surgical settings, which together create demand for devices that balance advanced clinical performance with operational efficiency; reimbursement models and public-private payer mixes also shape procurement priorities and evidence requirements.

Across Europe, the Middle East & Africa, regulatory diversity and heterogeneous payer landscapes necessitate flexible market entry strategies and adaptable clinical data packages. Device acceptance here often hinges on regional clinical opinion leaders and country-specific health technology assessment processes, making phased rollouts and local investigator-led studies valuable. In the Asia-Pacific region, rapid infrastructure development, increasing access to minimally invasive surgery, and variable domestic manufacturing capacity create opportunities for both innovative importers and locally based producers; procurement decisions frequently reflect a mix of cost sensitivity and a rising emphasis on clinical outcomes.

Taken together, these regional differences require manufacturers to tailor regulatory strategies, distribution partnerships, and clinical engagement plans. Strategic localization of evidence generation, targeted training programs for surgeons across differing procedural norms, and supply chain arrangements that reflect regional logistics realities will be decisive for commercial success.

A strategic synthesis of competitive forces, innovation focus areas, and partnership models that are redefining differentiation and value capture in hernia repair markets

Competitive dynamics in the hernia repair space reflect a balance between established surgical supply leaders and emerging innovators in biomaterials and fixation technologies. Leading firms continue to invest in iterative improvements to polymer and biologic scaffolds, enhanced delivery systems for minimally invasive procedures, and evidence generation that supports value-based procurement conversations. Meanwhile, smaller specialized players focus on disruptive material chemistries, surface modifications, and adjunct technologies such as antimicrobial coatings and absorbable fixation devices.

Partnerships between device manufacturers and clinical centers of excellence have become instrumental in accelerating adoption by demonstrating procedural efficiencies and patient-centric outcomes. Strategic collaborations with contract manufacturers and regional distributors further enable scale while managing cost structures. Intellectual property around material science and proprietary manufacturing processes remains a critical differentiator, as does the ability to integrate post-market surveillance and registries that document long-term performance.

As adoption criteria shift toward holistic value, companies that can present robust clinical evidence, streamlined logistics, and compelling surgeon training programs will maintain competitive advantage. Organizations should also monitor emerging entrants that leverage digital health adjuncts, such as surgical planning tools or analytics platforms, which can complement device offerings and create integrated value propositions for hospital systems and ambulatory centers alike.

Actionable, implementation-focused recommendations for leaders to align R&D, supply chain, and commercial models with clinical outcomes and payer expectations in hernia repair

Industry leaders can take decisive actions to convert emerging trends into sustainable advantages by aligning R&D, commercial, and operational priorities with clinical and payer demands. First, prioritize investment in materials and delivery systems that demonstrably improve integration, reduce infection risk, and simplify implantation for both open and laparoscopic techniques, supported by pragmatic clinical endpoints and real-world evidence collection initiatives. Second, establish cross-functional evidence-generation roadmaps that incorporate surgeon-led registries and post-market surveillance to satisfy regulators and purchasers while shortening the feedback loop for iterative product improvements.

Operationally, strengthen supply chain resilience by diversifying sources for critical inputs and exploring regional manufacturing options to mitigate tariff and logistics exposure. Cultivate robust training and proctoring programs tailored to ambulatory surgical center workflows and hospital operating suites, thereby reducing variation in clinical outcomes and accelerating institutional adoption. Finally, pursue value-driven commercial models that align pricing and reimbursement approaches with demonstrable clinical benefits and total episode-of-care efficiencies.

By executing these strategic moves, leaders will be positioned to navigate regulatory complexity, meet evolving clinical expectations, and secure durable partnerships with providers and payers. These recommendations emphasize practical implementation pathways that balance near-term operational resilience with long-term innovation-led differentiation.

A transparent, mixed-methods research design combining clinician insights, regulatory and clinical literature review, and supply chain scenario analysis to validate conclusions and recommendations

The research underpinning this executive synthesis integrates a structured combination of primary and secondary information-gathering methods designed to ensure analytical rigor and practical relevance. Primary inputs included structured interviews with clinical specialists across general and minimally invasive surgery, procurement leaders from ambulatory, clinic, and hospital settings, and subject-matter experts in biomaterials and regulatory affairs. These qualitative discussions informed hypothesis generation and prioritized areas for deeper analysis.

Secondary research encompassed peer-reviewed clinical literature, regulatory filings, device labeling information, and publicly available health policy documents to frame clinical performance attributes and regulatory trends. Comparative device characteristics and procedural technique literature were triangulated with real-world practice insights to validate clinical relevance. Supply chain and tariff scenario analysis relied on trade data, logistics expert commentary, and scenario planning methodologies to assess operational implications under different assumptions.

Analytical approaches combined thematic synthesis from qualitative interviews with cross-sectional comparative analyses of device attributes and care pathways. Quality assurance steps included cross-validation of key findings with multiple clinical sources and a review by external advisors to ensure objectivity. This mixed-methods approach supports actionable conclusions while maintaining methodological transparency and traceability.

A conclusive synthesis emphasizing the imperative to combine clinical evidence, operational resilience, and tailored commercialization to realize improved outcomes and sustainable value

In summary, the hernia repair field is at an inflection point driven by material innovation, procedural evolution toward minimally invasive care, and shifting procurement dynamics influenced by regional considerations and trade policy changes. Stakeholders who integrate rigorous clinical evidence generation with pragmatic supply chain and commercialization strategies will secure strategic advantages in a competitive landscape where clinical differentiation and operational efficiency matter equally.

Decision-makers should view device selection and partnership choices through a multidimensional lens that accounts for product attributes, procedural compatibility, patient outcomes, and care setting constraints. Regulatory and reimbursement dynamics necessitate an emphasis on demonstrable value, while tariff and supply chain considerations underscore the importance of operational resilience. Ultimately, organizations that align clinical innovation with real-world implementation plans-supported by targeted evidence and strong clinical partnerships-will be best positioned to deliver improved patient outcomes and sustainable commercial performance.

This report offers a foundation for such alignment and serves as a practical reference for clinical, commercial, and operational leaders seeking to translate insight into effective action within the evolving hernia repair landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia Repair Market, by Product Type

  • 8.1. Biological Mesh
    • 8.1.1. Animal
    • 8.1.2. Human
  • 8.2. Synthetic Mesh
    • 8.2.1. Polyester
    • 8.2.2. Polypropylene
    • 8.2.3. Polytetrafluoroethylene

9. Hernia Repair Market, by Procedure Type

  • 9.1. Laparoscopic
    • 9.1.1. Total Extraperitoneal
    • 9.1.2. Transabdominal Preperitoneal
  • 9.2. Open

10. Hernia Repair Market, by Hernia Type

  • 10.1. Hiatal
  • 10.2. Incisional
  • 10.3. Inguinal
  • 10.4. Umbilical
  • 10.5. Ventral

11. Hernia Repair Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Hernia Repair Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hernia Repair Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hernia Repair Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hernia Repair Market

16. China Hernia Repair Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AbbVie Inc.
  • 17.6. Aran Biomedical by Integer Holdings Corporation
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Becton, Dickinson and Company
  • 17.10. Betatech Medical
  • 17.11. BioCer Entwicklungs-GmbH
  • 17.12. Boston Scientific Corporation
  • 17.13. Coloplast A/S
  • 17.14. CooperSurgical, Inc.
  • 17.15. Cousin Surgery
  • 17.16. Deep Blue Medical Advances, Inc.
  • 17.17. Dolphin Sutures
  • 17.18. Getinge AB
  • 17.19. HERNIAMESH S.r.l.
  • 17.20. Hwainmedi Co., Ltd.
  • 17.21. Insightra Medical Inc.
  • 17.22. Integra LifeSciences Holdings Corporation
  • 17.23. Intuitive Surgical, Inc.
  • 17.24. Johnson & Johnson Services, Inc.
  • 17.25. KATSAN Katgut Sanayi ve Tic. A.S.
  • 17.26. Medtronic PLC
  • 17.27. Meril Life Sciences Pvt. Ltd.
  • 17.28. Momentis Surgical Ltd.
  • 17.29. Novus Scientific AB
  • 17.30. Olympus Corporation
  • 17.31. Secant Group, LLC
  • 17.32. Surgimatix, Inc.
  • 17.33. TELA Bio, Inc.
  • 17.34. W. L. Gore & Associates, Inc.
  • 17.35. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA REPAIR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA REPAIR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA REPAIR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HERNIA REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 143. GCC HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 144. GCC HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 146. GCC HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 167. G7 HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 168. G7 HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 170. G7 HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 175. NATO HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 176. NATO HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 178. NATO HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)